Camellia. API may win Sigma's customers

Stephen Roche, chief executive, of Australian Pharmaceutical Industries (API), at Camellia, said there were opportunities for the company to win customers from Sigma Pharmaceuticals, which is being forced by its banks to sell assets and cut generous credit terms to clients. API is one of Australia's leading health and beauty companies.

Camellia. API to expand Priceline stores

Australian Pharmaceutical Industries (API), based at Camellia, one of Australia’s leading health and beauty companies, aims to boost its 213 franchised Pricleine stores to 400 by early 2011. API has a number of brands and banners in the retail health and beauty industry, including Soul Pattinson, Pharmacist Advice as well as Priceline. API’s sales for the four months to December 31 rose 5.6 per cent over the corresponding period, while same store sales increased 2.2 per cent. “We were disappointed with some of the sale results (over the Christmas period) but the fact is we maintained margins,” CEO, Stephen Roche, said. API, which has 329 stores across Australia, opened 30 outlets over the past year.

Parramatta. 'Another tough year' for API

Australian Pharmaceutical Industries, based at Camellia, has forecast a first-half net profit to rise by as much as 10 per cent compared with a year ago but chairman, Peter Robinson, chairman, has warned, in The Australian Financial Review, it will be another tough year”for the company as the retail environment remains shaky.

API's sales recover

Sales of drug distributor and beauty products retailer, Australian Pharmaceutical Industries (API), based at Camellia, have risen by 18 per cent to $1.3 million in the first five months of fiscal 2008.MD, Stephen Roche, said further sales growth was a sign that the turnaround of the business was continuing. Former MD, Jeff Sher, resigned last year when API reported a net loss of $11.3 million.